Veracyte (VCYT) Announces New General Manager Structure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Nasdaq futures fall after Samsung's record profit fails to allay chip jitters
- Oil gains after vessel attacks near Strait of Hormuz
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Veracyte Announces New General Manager Structure to Advance Global Expansion
November 17, 2020 8:30 AM ESTJohn Hanna appointed GM, endocrinology, breast cancer and lymphoma;
Morten Frost to join company as GM, pulmonology
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte (Nasdaq: VCYT) today announced a new general manager-based structure to advance the companys growing roster of genomic tests and its global expansion.... More
